| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | Cytokinetics, Incorporated | Jun 30, 2026 | |
| Buy | Cytokinetics, Incorporated | Oct 9, 2025 | |
| Sell | Cytokinetics, Incorporated | Jun 17, 2025 | |
| Buy | Cytokinetics, Incorporated | Jun 11, 2025 |
This page tracks congressional stock trading activity in Cytokinetics, Incorporated (CYTK) in the Healthcare sector. Disclosed Capitol has indexed 4 disclosed congressional trades involving CYTK. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 4 disclosed congressional trades in Cytokinetics, Incorporated (CYTK) — 1 sells with no recorded buys — led by Gilbert Cisneros (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 30, 2026 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| Oct 9, 2025 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| Jun 17, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Jun 11, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
Across the 4 disclosed congressional trades in Cytokinetics, Incorporated (CYTK), members of Congress have reported 0 buys and 1 sell. The average 30-day alpha vs. the S&P 500 is -5.55%.
For fiscal year 2025, Cytokinetics, Incorporated reported revenue of $88.0M and net income of -$785.0M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $48.0M, net income -$404.8M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.